Physician profile
James Won
NPI 1245340439
$1,151.45
in general payments reported to CMS, 2019-2025
13 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $24.32 · 2023: $170 · 2024: $199 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $230.47 | 2024-2025 | |
| Catalyst Pharmaceuticals, INC. | $166.99 | 2025 | |
| Amgen INC. | $148.99 | 2023-2025 | Uplizna, Aimovig |
| Sk Life Science, INC. | $143.96 | 2024 | |
| Ani Pharmaceuticals, INC. | $105.66 | 2025 | Purified Cortrophin Gel |
| Livanova USA, INC. | $74.33 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Akcea Therapeutics, INC. | $69.01 | 2019 | |
| Sunovion Pharmaceuticals INC. | $60.59 | 2019-2020 | |
| Horizon Therapeutics Plc | $55.96 | 2023 | Uplizna |
| Averitas Pharma INC. | $29.03 | 2025 | Qutenza |
| Abbvie INC. | $27.38 | 2025 | |
| Avanir Pharmaceuticals, INC. | $19.63 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.45 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Won listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.